L. Ford

878 total citations
12 papers, 545 citations indexed

About

L. Ford is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, L. Ford has authored 12 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in L. Ford's work include Epilepsy research and treatment (3 papers), Neonatal and fetal brain pathology (2 papers) and Anesthesia and Neurotoxicity Research (2 papers). L. Ford is often cited by papers focused on Epilepsy research and treatment (3 papers), Neonatal and fetal brain pathology (2 papers) and Anesthesia and Neurotoxicity Research (2 papers). L. Ford collaborates with scholars based in United States, Belgium and Italy. L. Ford's co-authors include Mariëlle Eerdekens, F. Cañas, John M. Kane, Pilar Lim, Michelle Kramer, Cristiana Gassmann-Mayer, Linda A. DiMeglio, Paul R. Sanberg, Andrew B. Norman and M. Harold Fogelson and has published in prestigious journals such as Neurology, Bone and Schizophrenia Research.

In The Last Decade

L. Ford

11 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Ford United States	8	247	109	94	90	63	12	545
Farzana Hoda United Kingdom	11	131 0.5×	68 0.6×	139 1.5×	98 1.1×	63 1.0×	11	639
Ladislav Hosák Czechia	15	310 1.3×	44 0.4×	75 0.8×	108 1.2×	51 0.8×	57	807
Anna‐Greta Nylander Denmark	17	374 1.5×	57 0.5×	53 0.6×	186 2.1×	94 1.5×	33	905
Alma Mihaljević Peleš Croatia	15	222 0.9×	78 0.7×	53 0.6×	91 1.0×	13 0.2×	26	575
A Howard United States	13	563 2.3×	48 0.4×	143 1.5×	107 1.2×	24 0.4×	17	800
Dragoslav Sokić Serbia	14	361 1.5×	198 1.8×	34 0.4×	119 1.3×	37 0.6×	57	688
Nabilah I. Chowdhury Canada	15	286 1.2×	36 0.3×	160 1.7×	120 1.3×	22 0.3×	21	685
Kristina Melkersson Sweden	15	895 3.6×	85 0.8×	130 1.4×	94 1.0×	59 0.9×	42	1.3k
Juanjuan Xie China	11	102 0.4×	54 0.5×	29 0.3×	48 0.5×	61 1.0×	24	554
Eric Segal United States	12	310 1.3×	189 1.7×	47 0.5×	151 1.7×	22 0.3×	38	534

Countries citing papers authored by L. Ford

Since Specialization

Citations

This map shows the geographic impact of L. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Ford more than expected).

Fields of papers citing papers by L. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Ford. The network helps show where L. Ford may publish in the future.

Co-authorship network of co-authors of L. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of L. Ford. A scholar is included among the top collaborators of L. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Ford. L. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Eichenbaum, Gary, Michael F. Kelley, Calvert Louden, et al.. (2014). Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate. Regulatory Toxicology and Pharmacology. 69(2). 187–200. 7 indexed citations

Trenité, Dorothée Kasteleijn‐Nolst, John A. Moyer, Gahan Pandina, et al.. (2013). PP165—Evaluation of JNJ-26489112, a Novel Antiepileptic Drug: A Placebo-Controlled, Exploratory Study. Clinical Therapeutics. 35(8). e70–e70. 1 indexed citations

Novotny, Edward J., Ben Renfroe, Nandan Yardi, et al.. (2010). Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology. 74(9). 714–720. 32 indexed citations

Saper, JR, Seth Ness, Elena Polverejan, et al.. (2008). A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Neuropediatrics. 39(1).

Kane, John M., F. Cañas, Michelle Kramer, et al.. (2006). Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆. Schizophrenia Research. 90(1-3). 147–161. 229 indexed citations

DiMeglio, Linda A., et al.. (2005). A Comparison of Oral and Intravenous Bisphosphonate Therapy for Children with Osteogenesis Imperfecta. Journal of Pediatric Endocrinology and Metabolism. 18(1). 43–53. 38 indexed citations

DiMeglio, Linda A., et al.. (2004). Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. Bone. 35(5). 1038–1045. 64 indexed citations

Ford, L., et al.. (1999). Safety profile of ibuprofen suspension in young children. Inflammopharmacology. 7(3). 219–225. 38 indexed citations

Ford, L., et al.. (1995). Memory Impairment Induced by Intraamygdala β-Endorphin Is Mediated by Noradrenergic Influences. Neurobiology of Learning and Memory. 63(2). 200–205. 44 indexed citations

10.

Reynolds, Cecil R. & L. Ford. (1994). Comparative three-factor solutions of the WISC-III and WISR-R at 11 age levels between 6-1/2 and 16-1/2 years. Archives of Clinical Neuropsychology. 9(6). 553–570. 13 indexed citations

11.

Ford, L., Paul R. Sanberg, Andrew B. Norman, & M. Harold Fogelson. (1989). MK-801 Prevents Hippocampal Neurodegeneration in Neonatal Hypoxic-Ischemic Rats. Archives of Neurology. 46(10). 1090–1096. 78 indexed citations

12.

Ford, L., M. Harold Fogelson, Andrew B. Norman, & Paul R. Sanberg. (1988). Mk 801 prevents hypoxic ischemic hippocampal neurodegeneration in neonatal rats. The Society for Neuroscience Abstracts. 14(1). 368. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact